Category: Biotechnology
Global Biotechnology
-
CRISPR Technology
... CAGR of 20.9% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$6.1 Billion by the end of the analysis period. ... Read More
-
Tissue Engineering
... CAGR of 12.5% over the analysis period 2024-2030. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.7 Billion by the end of ... Read More
-
Bioengineered Protein Drugs
... at a CAGR of 4.2% over the analysis period 2024-2030. Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$129.2 Billion by the end of ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More
-
D-Amino Acids
... CAGR of 5.6% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$217.6 Million by the end of the analysis period. ... Read More
-
Biopreservation
... 8.0% over the analysis period 2024-2030. Biopreservation Media, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth ... Read More
-
3D Cell Culture
... at a CAGR of 13.9% over the analysis period 2024-2030. Scaffold-based, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Catalyst Carriers
... growing at a CAGR of 4.8% over the analysis period 2024-2030. Ceramics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach 95 Million Kilograms by the end ... Read More
-
DNA Sequencing
... CAGR of 11.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end of the analysis period. ... Read More
-
Cancer Therapies
... CAGR of 10.4% over the analysis period 2024-2030. Blood Cancer, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$119.2 Billion by the end of the analysis ... Read More
-
Gas Chromatography Systems
... at a CAGR of 4.9% over the analysis period 2024-2030. Accessories & Consumables, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.8 Billion by the end ... Read More
-
HPLC Systems and Accessories
... 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Pumps, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.7 Billion by the end ... Read More
-
Stem Cells
... CAGR of 7.4% over the analysis period 2024-2030. Adult Stem Cells, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$17.8 Billion by the end of the ... Read More
-
Nanocatalysts
... 6.6% over the analysis period 2024-2030. Refinery & Petrochemicals, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.8 Billion by the end of the analysis period. ... Read More
-
Small Molecule Kinase Inhibitors
... 2030, growing at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$27.8 Billion While China is Forecast to Grow at 14.6% CAGR The Small Molecule Kinase Inhibitors market ... Read More
-
Electrophoresis Equipment and Supplies
... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More
-
Pipettes and Pipettors
... at a CAGR of 5.7% over the analysis period 2024-2030. Pipette Tips, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Apoptosis
... 4.6% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More
-
qPCR and dPCR Instrumentation
... 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. qPCR, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
Commercial Biotechnology Separation Systems
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More
-
Human Microbiome
... CAGR of 28.4% over the analysis period 2024-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Medical Composites
... CAGR of 8.4% over the analysis period 2024-2030. Ceramic fiber composites, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Orthobiologics
... 4.2% over the analysis period 2024-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in ... Read More
Research Assistance
